Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250522005) titled 'Effectiveness of palliative re-irradiation with superficial hyperthermia in patients with unresectable recurrent squamous cell carcinoma of the head and neck' on May 22.

Study Type: Interventional

Study Design: N/A

Primary Sponsor: ABEX global healthcare,Thailand

Condition: Adverse effects will be evaluated using physical examination according to the RTOG toxicity score, specifically for radiation-induced dermatitis. Pain will be assessed using a visual analog scale (VAS), and quality of life will be assessed using the EQ-5D-5L Thai version questionnaire. dermatitis, hyperthermia, re-irradiation dermatitis, h...